
Insights on Deucravacitinib for Psoriasis During Expert Consensus Panel, with Hassan Hamade, MD
Following the conclusion of a recent expert consensus panel—the results of which were published in the Journal of Drugs in Dermatology—clinical recommendations on the use of deucravacitinib in psoriasis management were released.1 This panel’s findings, …